|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1988)) |
IUPAC Name ![]() |
| 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2λ5-oxazaphosphinan-2-one |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 2865 | ifosfamide |
Synonyms ![]() |
| Holoxan® |
| Ifex® |
| MJF-9325 |
| Z-4942 |
Database Links ![]() |
|
| CAS Registry No. | 3778-73-2 |
| ChEMBL Ligand | CHEMBL1024 |
| DrugBank Ligand | DB01181 |
| PubChem CID | 3690 |
| Search Google for chemical match using the InChIKey | HOMGKSMUEGBAAB-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | HOMGKSMUEGBAAB |
| Search PubMed clinical trials | ifosfamide |
| Search PubMed titles | ifosfamide |
| Search PubMed titles/abstracts | ifosfamide |
| Wikipedia | Ifosfamide |
| Comments |
| Ifosfamide is a DNA alkylating drug, and has additional immunosuppressant action. Ifosfamide is biologically inactive. In vivo metabolism is necessary to generate the active substance, isophosphamide mustard (IPM; PubChem CID 100427) [1]. |